REGENXBIO
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
RGNX Key Statistics
Stock Snapshot
As of today, REGENXBIO(RGNX) shares are valued at $7.43. The company's market cap stands at 493.78M, with a P/E ratio of -1.97.
During the trading session on 2026-09-28, REGENXBIO(RGNX) shares reached a daily high of $7.49 and a low of $7.17. At a current price of $7.43, the stock is +3.6% higher than the low and still -0.8% under the high.
Trading activity shows a volume of 1.24M, compared to an average daily volume of 1.54M.
Over the past 52 weeks, REGENXBIO(RGNX) stock has traded between a high of $16.19 and a low of $5.46.
Over the past 52 weeks, REGENXBIO(RGNX) stock has traded between a high of $16.19 and a low of $5.46.
RGNX News
...
REGENXBIO (RGNX) “announced positive long-term follow-up data from the Phase II ALTITUDE(R) study of investigational surabgene lomparvovec (sura-vec, ABBV-RGX-3...
An announcement from RegenXBio ( (RGNX) ) is now available. On September 23, 2026, REGENXBIO and the Trustees of the University of Pennsylvania reached a settl...
Analyst ratings
82%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.